A rationally‐designed scaffold of cyclic octapeptides composed of two units of the natural tripeptide glutathione (GSH) was optimized to strongly and selectively capture toxic lead ions (Pb(II)). Using state‐of‐the‐art computational tools, a list of eleven plausible peptides was shortened to five analogs based on their calculated affinity to Pb(II) ions. We then synthesized and investigated them for their abilities to recover Pb‐poisoned human cells. A clear pattern was observed from the in vitro detoxification results, indicating the importance of cavity size and polar moieties to enhance metal capturing. These, together with the apparent benefit of cyclizing the peptides, improved the detoxification of the two lead peptides by approximately two folds compared to GSH and the benchmark chelating agents against Pb poisoning. Moreover, the two peptides did not show any toxicity and, therefore, were thoroughly investigated to determine their potential as next‐generation remedies for Pb poisoning.
The Front Cover shows the process of candidate optimization within a family of cyclic octapeptides designed to tightly and selectively bind toxic lead ions. Similar to playing tic tac toe, three parameters must align to achieve the desired outcome and identify the winner peptide. While several members weakly bound lead and others prioritized essential metal ions, only three peptides succeeded in recovering lead‐poisoned human cells due to their high lead affinity and selectivity, emphasizing the potential of the rationally designed scaffold. Cover design by Dr. Michel Rickhaus. More information can be found in the Research Article by Michal S. Shoshan et al.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.